Pluronic® block copolymers: Novel functional molecules for gene therapy

Advanced Drug Delivery Reviews

Volumn 54, Issue 2, 2002, Pages 223-233

  Kabanov, Alexander V ^a   Lemieux, Pierre ^b   Vinogradov, Sergey ^a   Alakhov, Valery ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Supratek Pharma Inc   (Canada)

Author keywords

Block copolymer; DNA; Gene delivery; Gene therapy; Poly(ethylene glycol); Polycation

Indexed keywords

COPOLYMERS; GENES; MOLECULAR WEIGHT; MUSCLE; POLYPEPTIDES;

MOLECULAR MASS DRUGS;

DRUG PRODUCTS PLANTS;

ADJUVANT; COPOLYMER; OLIGONUCLEOTIDE; POLOXAMER; POLYCATION; RECOMBINANT DNA;

ARTICLE; CONJUGATE; DRUG EFFECT; DRUG FORMULATION; DRUG RESPONSE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE STRUCTURE; GENE THERAPY; MEDICAL LITERATURE; MEDICAL RESEARCH; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; STRUCTURE ANALYSIS; SYNTHESIS; TRANSGENE; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; GENETICS; HUMAN; METHODOLOGY; REVIEW;

ANIMALS; DRUG DELIVERY SYSTEMS; GENE EXPRESSION; GENE THERAPY; HUMANS; OLIGONUCLEOTIDES; POLOXAMER; TRANSGENES;

EID: 0037148596     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00018-2     Document Type: Article

References (77)

1. Nomenclature for synthetic gene delivery systems
2. Viral and non-viral vectors for cancer gene therapy
3. Taking polycation gene delivery systems from in vitro to in vivo
4. Cationic polymer based gene delivery systems
5. Plasmid delivery to muscle: Recent advances in polymer delivery systems
6. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle
7. Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle
8. A review of block polymer surfactants
9. Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic (PEO-PPO-PEO) block copolymers
10. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting
11. A new class of drug carriers: Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain
12. Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407
13. Thermal-induced denaturation of two model proteins: Effect of poloxamer 407 on solution stability
14. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti-cancer activity
15. Block copolymeric biotransport carriers as versatile vehicles for drug delivery
16. Stabilization and activation of Pluronic micelles for tumor-targeted drug delivery
17. Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: Effect of micelle structure and ultrasound on the intracellular drug uptake
18. Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers
19. The adjuvant activity of fatty acid esters. The role of acyl chain length and degree of saturation
20. The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance
21. The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers
22. The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces
23. Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody
24. Mechanisms of action of nonionic block copolymer adjuvants
25. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity
26. Adjuvant formulations and their mode of action
27. Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity
28. Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways
29. Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine
30. Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors
31. Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns
32. Pharmacokinetics of a new skin wound cleanser
33. Pluronic F-68: A promising new skin wound cleanser
34. Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs
35. A new silver sulfadiazine water soluble gel
36. Role of poloxamer 188 during recovery from ischemic spinal cord injury: A preliminary study
37. An amorphous hydrogel enhances epithelialisation of wounds
38. Tissue-engineered nipple reconstruction
39. Effect of a composite membrane of chitosan and poloxamer gel on postoperative adhesive interactions
40. Reduction of postoperative adhesions in the rat uterine horn model with poloxamer 407
41. Surfactant sealing of membranes permeabilized by ionizing radiation
42. Transient and stable ionic permeabilization of isolated skeletal muscle cells after electrical shock
43. Pharmaceutical therapies for sealing of permeabilized cell membranes in electrical injuries
44. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer
45. Selective energy depletion and sensitization of multiple drug resistant cancer cells by Pluronic block copolymers
46. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion
47. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells
48. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells
49. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials
50. Direct gene transfer into mouse muscle in vivo
51. Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5
52. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector
53. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study
54. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: Anesthetic management and results
55. Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice
56. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation
57. Technology evaluation: VEGF165 gene therapy, Valentis Inc
58. Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity
59. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma
60. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle
61. Block copolymeric biotransport carriers as versatile vehicles for drug delivery
62. Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates
63. Toxicological evaluation of poloxamer vehicles for intramuscular use
64. Enhancement of the polycation-mediated DNA uptake and cell transfection with Pluronic P85 block copolymer
65. Evaluation of polyplexes as gene transfer agents
66. Improvement of receptor-mediated gene delivery to HepG2 cells using an amphiphilic gelling agent
67. Improvement of gene transfer to cervical cancer cell lines using non-viral agents
68. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents
69. Pluronic-polyethyleneimine conjugates for gene delivery: Cell transport and transgene expression
70. Water-soluble block polycations for oligonucleotide delivery
71. Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides
72. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells
73. Reduction of fibronectin expression by intravitreal administration of antisense oligonucleotides
74. Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic copolymer in physiological saline
75. Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers
76. Altered organ accumulation of oligonucleotides using polyethyleneimine grafted with poly(ethylene oxide) or pluronic as carriers